Northreach is a dynamic talent solutions specialist that connects businesses with top talent in the cell & gene therapy, fintech, and digital sectors. Our mission is to provide a seamless and personalised recruitment experience for clients and candidates, and to create a positive work environment that encourages equality, innovation, and professional growth.
We have an opportunity for a talented and highly motivated scientific leader to join an exciting new business venture focused on applying the company’s proprietary gene silencing platform (GEiGS) to the development of novel human therapeutics.
The GEiGS technology facilitates Stable, Tunable and Programmable silencing activity that differentiates it from alternative gene editing or gene regulation approaches, and specifically enables production of programmable, next-generation advanced therapies, addressing many current limitations.
The appointee will be joining a multidisciplinary team of computational and experimental biologists. The post is ideal for a dynamic individual looking to be part of a cutting-edge research program that will also have real impact on patients’ lives. Due to the early stage nature of the company it is imperative to have a pragmatic, can-do, collaborative approach.
Responsibilities
- Drives translational strategy across a range of therapeutic indications and target mechanisms, with an initial focus on oncology.
- Leads a team of expert biologists, along with external collaborations, that effectively support the development of GEiGS-enabled therapeutics to the clinic.
- Collaborates with Senior Management team, Bioinformatics and Research Operations functions to develop the strategic vision for product development.
- Communicates scientific progress to SMT and to internal and external audiences.
Who You Are:
- Proven track record in driving programs from concept definition to completion of IND-enabling studies, ideally with experience in advanced therapy-based modalities/immuno-oncology.
- Demonstrated expertise in developing pre-clinical plans and effectively communicating with KOLs/SABs, clinicians, and regulatory authorities.
- Ability to resolve ambiguity and progress a portfolio of complex therapeutic concepts.
- A natural leader, able to galvanize collaborators, who thrives in a scientifically diverse, fast-paced, team-oriented, start-up environment.
- Prior experience in leading development of a novel therapeutic mechanism of action is considered a plus.
- Knowledge of in-vivo gene editing approaches would be advantageous.
Qualifications / Profile:
- Ph.D with extensive industry experience (Ph.D +10yrs).
- Outstanding communication skills with proven ability to relay information effectively and efficiently, both to computational and experimental scientists.
- Team-orientation toward collaboration and mutual success.
Working at the company:
You will be welcomed by a team of passionate, experienced and collaborative colleagues, happy to help you develop your own skills and to facilitate your personal/career development.
Work life balance:
We put people at the heart of our business. Every member of our team is important to us and our business is structured to offer generous rewards as well as excellent career and training opportunities. Check out our benefits listed below:
- 25 days annual leave, plus Bank Holidays, rising to 30 after 5 years service.
- Family & well being.
- Group Pension Plan.
- Private medical health insurance.
- Group Income Protection.
- Social events.
Compensation: We offer a competitive compensation package to successful candidates.
Northreach is an equal opportunity employer and we do not discriminate against any employee or applicant for employment based on race, colour, religion, sex, national origin, disability, or age. We are committed to promoting diversity, equity, and inclusion in the workplace and hiring practices, therefore only partner with business that promote DEI. We strive to create a welcoming and inclusive environment for all employees.